Startups
Genovac is a company that offers a unique combination of advanced antibody discovery tools. Their innovative immunization technologies, single B cell screening platforms, and multiple species options position them to deliver success against challenging targets. They offer their clients everything from cDNA synthesis to large-scale antibody production.
Genovac offers antibody discovery solutions. Its immunization technologies combined with its advanced hybridoma and Berkeley Lights Beacon platform provide success against challenging targets. It partners with transgenic animal companies and offers everything from cDNA synthesis to antibody sequencing.
Genovac operates a second scientific and production facility in Freiburg, Germany. Since its founding in 1999, Genovac has completed more than 3, projects, providing antibodies to clients in North America, Europe, Australia and Asia that have been developed into clinical and commercial drugs.
Genovac offers antibody discovery solutions. Its immunization technologies combined with its advanced hybridoma and Berkeley Lights Beacon platform provide success against challenging targets. It partners with transgenic animal companies and offers everything from cDNA synthesis to antibody sequencing.
Genovac operates a second scientific and production facility in Freiburg, Germany. Since its founding in 1999, Genovac has completed more than 3, projects, providing antibodies to clients in North America, Europe, Australia and Asia that have been developed into clinical and commercial drugs.
Overview
Location
United States, North Dakota, Fargo
Employees
51-200
Founded date
1999
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 20, 2022 | Genovac Acquires Carterra LSA® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services | Genovac becomes Carterra’s 100th LSA placement throughout the world We’re thrilled to add Carterra’s LSA, the most advanced, high-throughput epitope binning and affinity measuring platform in the world, to our Fargo facility.” — Brian Walte... |
| May 25, 2021 | Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems | Berkeley LightsBerkeley Lights |
| Apr 26, 2021 | Genovac Antibody Discovery Launches in NDSU Research and Technology Park | Fargo, North Dakota, April 26, 2021 (GLOBE NEWSWIRE) -- Genovac Antibody Discovery has launched in the United States following a management buyout of an antibody discovery business unit owned by Aldevron, a U.S.-based contract manufacturing... |
Reviews 0
FAQ about Genovac
When was Genovac founded?
Genovac was founded in 1999.
What has the press written about Genovac?
Parsers VC has collected 4 articles mentioning Genovac, among them “Genovac Acquires Carterra LSA® Instrument to Enable State-of-the-Art Antibody Screening and Characterization Services” (Apr 20, 2022) and “Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems” (May 25, 2021).
Is Genovac still active?
Yes, Genovac is active; its latest activity on Parsers VC dates from Mar 13, 2023.